HomeNDC LookupRxCUI directory › RxCUI 1306898

24 HR hydromorphone hydrochloride 32 MG Extended Release Oral Tablet — RxCUI 1306898

RxNorm drug concept · Semantic clinical drug
RxCUI 1306898 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 16 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1306898
Official name24 HR hydromorphone hydrochloride 32 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asHYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)606 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydromorphone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Hydromorphone injection is used to treat severe pain when other pain medicines haven't worked well enough. It's an opioid — a strong prescription pain reliever — and it's typically...
  • What is hydromorphone injection used for?
  • Common side effects include dizziness, drowsiness, nausea, vomiting, itching, sweating, dry mouth, and constipation — these are typical with opioids. But if your breathing feels ve...
  • What side effects should I expect, and which ones mean I need to call for help right away?
📖 Read our full Hydromorphone Injection guide →

🕸️ Concept Web — How 24 HR hydromorphone hydrochloride 32 MG Extended... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR hydromorphone hydrochloride 32 MG Extended Release Oral Tablet RxCUI 1306898

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydromorphone 3423
    • Hydromorphone hydrochloride 203177
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydromorphone Extended Release Oral Tablet 902728
    • Hydromorphone hydrochloride Extended Release Oral Tablet 2649153
    • Hydromorphone Oral Product 1164620
    • Hydromorphone Pill 1164621
    • Hydromorphone hydrochloride Oral Product 2659874
    • Hydromorphone hydrochloride Pill 2661455
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydromorphone hydrochloride 32 MG 897736

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydromorphone hydrochloride 32 MG SCDC · 897736
  • Hydromorphone Extended Release Oral Tablet SCDF · 902728
  • Hydromorphone hydrochloride Extended Release Oral Tablet SCDFP · 2649153
  • Hydromorphone Oral Product SCDG · 1164620
  • Hydromorphone Pill SCDG · 1164621
  • Hydromorphone hydrochloride Oral Product SCDGP · 2659874
  • Hydromorphone hydrochloride Pill SCDGP · 2661455

📦 FDA Products & Package NDCs

16 products · 16 package NDCs
16 package NDCs map to RxCUI 1306898 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00574-0293-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0293-01) hydromorphone hydrochloride Padagis US LLC 2015-05-22
00574-0294-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0294-01) hydromorphone hydrochloride Padagis US LLC 2015-05-22
00574-0295-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01) hydromorphone hydrochloride Padagis US LLC 2015-05-22
00574-0297-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0297-01) hydromorphone hydrochloride Padagis US LLC 2017-09-29
13811-0701-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-701-10) Hydromorphone Hydrochloride Trigen Laboratories, LLC 2016-09-15
13811-0702-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10) Hydromorphone Hydrochloride Trigen Laboratories, LLC 2016-09-15
13811-0703-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-703-10) Hydromorphone Hydrochloride Trigen Laboratories, LLC 2016-09-15
13811-0704-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-704-10) Hydromorphone Hydrochloride Trigen Laboratories, LLC 2016-09-15
31722-0119-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-119-01) hydromorphone hydrochloride Camber Pharmaceuticals, Inc. 2020-09-24
31722-0120-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-120-01) hydromorphone hydrochloride Camber Pharmaceuticals, Inc. 2020-09-24
31722-0121-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-121-01) hydromorphone hydrochloride Camber Pharmaceuticals, Inc. 2020-09-24
31722-0122-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-122-01) hydromorphone hydrochloride Camber Pharmaceuticals, Inc. 2020-09-24
72865-0168-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-168-01) hydromorphone hydrochloride XLCare Pharmaceuticals, Inc. 2020-09-24
72865-0169-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-169-01) hydromorphone hydrochloride XLCare Pharmaceuticals, Inc. 2020-09-24
72865-0170-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-170-01) hydromorphone hydrochloride XLCare Pharmaceuticals, Inc. 2020-09-24
72865-0171-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-171-01) hydromorphone hydrochloride XLCare Pharmaceuticals, Inc. 2020-09-24
Observed labelers: Camber Pharmaceuticals, Inc. (4) · Padagis US LLC (4) · Trigen Laboratories, LLC (4) · XLCare Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.